Description
Parabolan LA PHARMA Injection – 100 mg/amp.
Generic name – trenbolone acetate
Parabolan with its trenbolone acetate base is a top rated product, considered by many as an all-purpose steroid, when it comes to bulking, cutting, improving energy and strength levels, etc. Its powers are considered 5x more powerful than testosterone itself.
Trenbolone basis is divided between acetate ester and enanthate ester base. Tren Acetate is better when it comes to maintaining stable blood value levels. why? Because human body can sustain higher dose of trenbolone when injected with the acetate form rather than in the enanthate form, meanwhile Trenbolone acetate peaks in a body fasters and because of different half life leaves body faster.
It is better to use trenbolone acetate rather then enanthate when one seeks muscle hardening and cutting
By enhancement of nutrient and protein synthesis in the muscle tissue one can get stronger and more ripped muscles and also enhance of the nitrogen retention for more endurance during work-out.
If there is excessive body fat present, it will burn out because product helps with conversion of energy. Parabolan will also support the production of anabolic growth hormones for added bulking and repair of muscle tissue. As a result you get improved muscle recovery and overall body recovery.
Trenbolon acetate does not aromatize, so the level of estrogen wont rise and minimizes the risks of side effects.
Parabolan Dosage
Trenbolone acetate cycle is 8 weeks long for beginners, where dosage is 300mg/week ideally used with testosterone propionate at 400mg/week.
For the intermediate users we recommend also 8 weeks cycle with dosage of 400mg/week Trenbolone acetate, 100mg/week dose of testosterone propionate and starting with the 4th week of the cycle Dianobol added with dosage 25/50mg a day.
For the experienced users cycle of 12 weeks is advised with dosage of Trenbolone enanthate 800mg/week, testosterone enanthate 100mg/week, drostanolone enanthate 400mg/week.
Reviews
There are no reviews yet.